CZ237499A3 - Water suspension for nasal administration - Google Patents

Water suspension for nasal administration

Info

Publication number: CZ237499A3
Authority: CZ; Czechia
Prior art keywords: nasal administration; water suspension; suspension; water; nasal
Prior art date: 1997-01-16

Application number

CZ19992374A

Other languages

Czech (cs)

Other versions

CZ294919B6 (en

Inventor

Koji Doi

Original Assignee

Bodor Nicholas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-16

Filing date

1998-01-14

Publication date

2000-01-12

1998-01-14 Application filed by Bodor Nicholas filed Critical Bodor Nicholas

2000-01-12 Publication of CZ237499A3 publication Critical patent/CZ237499A3/en

2005-04-13 Publication of CZ294919B6 publication Critical patent/CZ294919B6/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

CZ19992374A 1997-01-16 1998-01-14 Aqueous suspension for nasal administration CZ294919B6 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP1966497		1997-01-16

Publications (2)

Publication Number	Publication Date
CZ237499A3 true CZ237499A3 (en)	2000-01-12
CZ294919B6 CZ294919B6 (en)	2005-04-13

Family

ID=12005518

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CZ19992374A CZ294919B6 (en)	1997-01-16	1998-01-14	Aqueous suspension for nasal administration

Country Status (32)

Country	Link
US (1)	US6368616B1 (en)
EP (1)	EP0973501B1 (en)
KR (1)	KR100471708B1 (en)
CN (1)	CN1126535C (en)
AR (1)	AR011773A1 (en)
AT (1)	ATE249205T1 (en)
AU (1)	AU730953C (en)
BR (1)	BR9806771A (en)
CA (1)	CA2278025C (en)
CZ (1)	CZ294919B6 (en)
DE (1)	DE69818026T2 (en)
DK (1)	DK0973501T3 (en)
EA (1)	EA001775B1 (en)
ES (1)	ES2206880T3 (en)
HU (1)	HU226613B1 (en)
ID (1)	ID21892A (en)
IL (1)	IL130979A0 (en)
LT (1)	LT4677B (en)
LV (1)	LV12449B (en)
MX (1)	MXPA99006628A (en)
NO (1)	NO324619B1 (en)
NZ (2)	NZ509908A (en)
PL (1)	PL190753B1 (en)
PT (1)	PT973501E (en)
RS (1)	RS49701B (en)
SI (1)	SI20057A (en)
SK (1)	SK283164B6 (en)
TR (1)	TR199901663T2 (en)
TW (1)	TW503113B (en)
UA (1)	UA52722C2 (en)
WO (1)	WO1998031343A2 (en)
ZA (1)	ZA98303B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI243687B (en)	1998-04-21	2005-11-21	Teijin Ltd	Pharmaceutical composition for application to mucosa
ATE331532T1 (en)	1998-08-26	2006-07-15	Teijin Ltd	POWDERED PERNASALE PRODUCTS
DE19947235A1 (en) *	1999-09-30	2001-04-05	Asta Medica Ag	New combination of loteprednol and beta¶2¶ adrenoreceptor agonists
AR026073A1 (en)	1999-10-20	2002-12-26	Nycomed Gmbh	PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE
US6565832B1 (en) *	2000-01-31	2003-05-20	Schering-Plough Healthcare Products, Inc.	Spray composition with reduced dripping
WO2002102390A1 (en) *	2001-06-18	2002-12-27	Noven Pharmaceuticals, Inc.	Enhanced drug delivery in transdermal systems
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
US8912174B2 (en) *	2003-04-16	2014-12-16	Mylan Pharmaceuticals Inc.	Formulations and methods for treating rhinosinusitis
US7811606B2 (en) *	2003-04-16	2010-10-12	Dey, L.P.	Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) *	2003-04-16	2017-11-07	Mylan Specialty Lp	Nasal pharmaceutical formulations and methods of using the same
DE602004008083T2 (en) *	2003-06-19	2008-04-24	Nicholas S. Gainsville Bodor	REINFORCEMENT OF THE ACTIVITY AND / OR DURABILITY OF SELECTED INFLAMMATORY STEROIDS
JP4893305B2 (en) *	2003-06-19	2012-03-07	ボーダー、ニコラス・エス	Enhancement of the activity and / or duration of action of soft anti-inflammatory steroids for topical or other topical administration
US20050095205A1 (en) *	2003-10-31	2005-05-05	Ramesh Krishnamoorthy	Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
WO2005094836A2 (en)	2004-03-25	2005-10-13	Bausch & Lomb Incorporated	Use of loteprednol etabonate for the treatment of dry eye
US20070099883A1 (en) *	2005-10-07	2007-05-03	Cheryl Lynn Calis	Anhydrous mometasone furoate formulation
US20070110812A1 (en) *	2005-11-14	2007-05-17	Bausch & Lomb Incorporated	Ophthalmic composition for dry eye therapy
US7691811B2 (en) *	2006-05-25	2010-04-06	Bodor Nicholas S	Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
US7687484B2 (en) *	2006-05-25	2010-03-30	Bodor Nicholas S	Transporter enhanced corticosteroid activity
WO2012119261A1 (en) *	2011-03-10	2012-09-13	Biocia Inc.	Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
WO2013043387A1 (en)	2011-09-22	2013-03-28	Bausch & Lomb Incorporated	Ophthalmic gel compositions
MX2020001525A (en)	2017-08-24	2020-03-20	Novo Nordisk As	COMPOSITIONS OF GLUCAGON-LIKE PEPTIDE TYPE 1 (GLP-1) AND THEIR USES.
IL294521A (en)	2020-02-18	2022-09-01	Novo Nordisk As	Glp-1 compositions and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5540930A (en) *	1993-10-25	1996-07-30	Pharmos Corporation	Suspension of loteprednol etabonate for ear, eye, or nose treatment
EP0709099A3 (en) *	1994-09-28	1996-07-24	Senju Pharma Co	An aqueous nasal suspension comprising cyclodextrin
KR100508227B1 (en)	1997-03-14	2006-03-23	센주 세이야꾸 가부시키가이샤	Aqueous suspension of loteprednol etabonate

1998
- 1998-01-06 TW TW087100103A patent/TW503113B/en not_active IP Right Cessation
- 1998-01-14 RS YUP-361/99A patent/RS49701B/en unknown
- 1998-01-14 US US09/341,522 patent/US6368616B1/en not_active Expired - Fee Related
- 1998-01-14 KR KR10-1999-7006440A patent/KR100471708B1/en not_active Expired - Fee Related
- 1998-01-14 AT AT98900360T patent/ATE249205T1/en not_active IP Right Cessation
- 1998-01-14 NZ NZ509908A patent/NZ509908A/en unknown
- 1998-01-14 SI SI9820018A patent/SI20057A/en not_active IP Right Cessation
- 1998-01-14 UA UA99084658A patent/UA52722C2/en unknown
- 1998-01-14 PT PT98900360T patent/PT973501E/en unknown
- 1998-01-14 IL IL13097998A patent/IL130979A0/en not_active IP Right Cessation
- 1998-01-14 ZA ZA98303A patent/ZA98303B/en unknown
- 1998-01-14 NZ NZ336990A patent/NZ336990A/en unknown
- 1998-01-14 BR BR9806771-0A patent/BR9806771A/en not_active IP Right Cessation
- 1998-01-14 HU HU0002473A patent/HU226613B1/en not_active IP Right Cessation
- 1998-01-14 CZ CZ19992374A patent/CZ294919B6/en not_active IP Right Cessation
- 1998-01-14 SK SK948-99A patent/SK283164B6/en not_active IP Right Cessation
- 1998-01-14 MX MXPA99006628A patent/MXPA99006628A/en not_active IP Right Cessation
- 1998-01-14 DK DK98900360T patent/DK0973501T3/en active
- 1998-01-14 ES ES98900360T patent/ES2206880T3/en not_active Expired - Lifetime
- 1998-01-14 PL PL334614A patent/PL190753B1/en not_active IP Right Cessation
- 1998-01-14 ID IDW990725A patent/ID21892A/en unknown
- 1998-01-14 CA CA002278025A patent/CA2278025C/en not_active Expired - Fee Related
- 1998-01-14 WO PCT/JP1998/000108 patent/WO1998031343A2/en not_active Ceased
- 1998-01-14 EA EA199900659A patent/EA001775B1/en not_active IP Right Cessation
- 1998-01-14 TR TR1999/01663T patent/TR199901663T2/en unknown
- 1998-01-14 CN CN98803402A patent/CN1126535C/en not_active Expired - Fee Related
- 1998-01-14 EP EP98900360A patent/EP0973501B1/en not_active Expired - Lifetime
- 1998-01-14 DE DE69818026T patent/DE69818026T2/en not_active Expired - Fee Related
- 1998-01-14 AU AU54952/98A patent/AU730953C/en not_active Ceased
- 1998-01-16 AR ARP980100191A patent/AR011773A1/en active IP Right Grant
1999
- 1999-07-13 NO NO19993453A patent/NO324619B1/en not_active IP Right Cessation
- 1999-07-15 LV LVP-99-109A patent/LV12449B/en unknown
- 1999-08-12 LT LT99-100A patent/LT4677B/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
CZ294919B6 (en)	2005-04-13
NO993453D0 (en)	1999-07-13
IL130979A0 (en)	2001-01-28
WO1998031343A2 (en)	1998-07-23
NO324619B1 (en)	2007-11-26
ATE249205T1 (en)	2003-09-15
CA2278025A1 (en)	1998-07-23
WO1998031343A3 (en)	1998-09-17
HUP0002473A2 (en)	2000-12-28
LV12449A (en)	2000-04-20
CN1250370A (en)	2000-04-12
BR9806771A (en)	2000-05-16
CN1126535C (en)	2003-11-05
HU226613B1 (en)	2009-04-28
AU730953B2 (en)	2001-03-22
LV12449B (en)	2000-09-20
DE69818026T2 (en)	2004-07-08
SK94899A3 (en)	2000-05-16
PT973501E (en)	2004-02-27
ZA98303B (en)	1998-07-20
NZ336990A (en)	2001-03-30
AU730953C (en)	2002-02-07
KR20000070214A (en)	2000-11-25
SI20057A (en)	2000-04-30
LT4677B (en)	2000-07-25
ES2206880T3 (en)	2004-05-16
TR199901663T2 (en)	1999-09-21
CA2278025C (en)	2005-09-06
US6368616B1 (en)	2002-04-09
TW503113B (en)	2002-09-21
KR100471708B1 (en)	2005-03-07
NO993453L (en)	1999-07-13
AU5495298A (en)	1998-08-07
PL334614A1 (en)	2000-03-13
EA199900659A1 (en)	2000-02-28
SK283164B6 (en)	2003-03-04
HUP0002473A3 (en)	2001-01-29
EP0973501A2 (en)	2000-01-26
AR011773A1 (en)	2000-09-13
RS49701B (en)	2007-12-31
EP0973501B1 (en)	2003-09-10
DE69818026D1 (en)	2003-10-16
LT99100A (en)	2000-02-25
NZ509908A (en)	2004-12-24
MXPA99006628A (en)	2005-01-10
HK1026138A1 (en)	2000-12-08
PL190753B1 (en)	2006-01-31
UA52722C2 (en)	2003-01-15
DK0973501T3 (en)	2004-01-19
EA001775B1 (en)	2001-08-27
ID21892A (en)	1999-08-05
YU36199A (en)	2002-09-19

Publication	Publication Date	Title
CZ237499A3 (en)	2000-01-12	Water suspension for nasal administration
GB2324040B (en)	2001-06-06	Laryngeal mask
PL334447A1 (en)	2000-02-28	Inhaler
PL335799A1 (en)	2000-05-22	Inhaler
GB2331932B (en)	2002-05-22	Laryngeal mask
AU135548S (en)	1998-11-02	Inhaler
PL335690A1 (en)	2000-05-08	Inhaler
GB9726916D0 (en)	1998-02-18	Nasal formulation
PL335701A1 (en)	2000-05-08	Inhaler
AU135120S (en)	1998-09-21	Inhaler
GB9705585D0 (en)	1997-05-07	Laryngeal mask assemlies
ZA983852B (en)	1998-11-13	Therapy for constipation
US5865452C1 (en)	2001-02-27	Steerable suspension system
GB2317234B (en)	2000-12-27	Suspended body flowmeter
GB2320900B (en)	2000-08-30	Inhalers
GB2329340B (en)	2002-04-24	Breathing aid
GB9705071D0 (en)	1997-04-30	Nebuliser
GB2365338B (en)	2002-04-03	Therapeutic systems
GB9721597D0 (en)	1997-12-10	(Nasal) breathing aid
GB9608255D0 (en)	1996-06-26	Nasal intubation
ZA983168B (en)	1998-10-20	New naphthylpiperazine derivatives
CA79927S (en)	1997-02-07	Nasal mask
GB9718816D0 (en)	1997-11-12	Extracorporeal system
GB9706882D0 (en)	1997-05-21	Suspension system
GB9605685D0 (en)	1996-05-22	Nasal insert

Legal Events

Date	Code	Title	Description
2000-06-30	PD00	Pending as of 2000-06-30 in czech republic
2010-08-04	MM4A	Patent lapsed due to non-payment of fee	Effective date: 20100114